首页> 外文期刊>Clinical & translational oncology : >Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
【24h】

Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma

机译:鼻咽癌保形放射治疗与调强放射治疗的结果及预后

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: This study retrospectively compared outcomes and prognostic factors of nasopharyngeal carcinoma (NPC) treated with conformal radiotherapy (CRT) and intensity-modulated radiotherapy (IMRT). Materials and methods: The treatment records of 182 patients treated with IMRT and 198 patients treated with CRT from April 2005 to December 2007 in our hospital were reviewed. The clinical characteristics, treatment outcomes (including survival analysis and acute and late toxicity), and prognostic factors of the two groups were compared. Results: The 4-year local-regional control (LRC), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) of the IMRT and CRT groups were 93.6 and 85.3 %, 79.1 and 73.6 %, 74.7 and 65.0 %, and 83.5 and 72.1 %, respectively. The acute radiation dermatitis and xerostomia of the two groups were significantly different (P<0.05). In the IMRT group, OS between different T stages could not be well separated. Multivariate analysis revealed that, in the CRT group, the clinical stage and T and N stages were significant prognostic factors for OS, DMFS, and DFS and that T stage was a significant prognostic factor for LRC. In the IMRT group, T and N stages had no predictive value for outcomes. Conclusions: Compared with CRT, IMRT has a better prognosis and less adverse effects. For IMRT, T stage was not a significant prognostic factor for LRC, DMFS, DFS, or OS. An effective treatment strategy is needed for distant control. With the increasing use of IMRT and continued modulation of treatment strategies for NPC, the current staging system faces great challenges.
机译:简介:本研究回顾性比较了保形放疗(CRT)和调强放疗(IMRT)治疗的鼻咽癌(NPC)的结局和预后因素。资料与方法:回顾分析我院2005年4月至2007年12月收治的182例IMRT和198例CRT的治疗记录。比较两组的临床特征,治疗结果(包括生存分析以及急性和晚期毒性)以及预后因素。结果:IMRT和CRT组的4年局部控制(LRC),远处无转移生存(DMFS),无病生存(DFS)和总体生存(OS)分别为93.6和85.3%,79.1分别为73.6%,74.7和65.0%,以及83.5和72.1%。两组急性放射性皮肤炎和口干有显着性差异(P <0.05)。在IMRT组中,不同T级之间的OS无法很好地分离。多因素分析显示,在CRT组中,临床分期,T和N分期是OS,DMFS和DFS的重要预后因素,而T分期是LRC的重要预后因素。在IMRT组中,T和N期对预后没有预测价值。结论:与CRT相比,IMRT预后较好,不良反应较少。对于IMRT,T期不是LRC,DMFS,DFS或OS的重要预后因素。需要有效的治疗策略来进行远距离控制。随着IMRT的使用不断增加以及NPC治疗策略的不断调整,当前的分期系统面临巨大挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号